Eugia Pharma receives USFDA Approval for Leuprolide Acetate Injection
he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.
he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.
The campaign aims to promote women’s health and wellness and urge them to visit the hospital for key medical check-ups
India accounts for more than half (almost 60%) of new leprosy cases worldwide, despite being declared ‘leprosy-free’ in 2005.
The Home Healthcare market is expected to be US $ 14.2 by 2025
The funds will be used to scale up existing operations and launch new products
Cryo-technology helps in early diagnosis and palliative care in later stages of cancer
Continuum care is a concept that’s gaining acceptance in South India and Sukino Healthcare with its presence in Bangalore and Kochi has made rapid strides catering to this need. It now plans to expand to many more cities in the region. Indian Pharma Post caught up with Rajinish Menon, Founder & CEO, Sukino Healthcare who gave us an insight into the company’s operations.
Subscribe To Our Newsletter & Stay Updated